Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 251

1.

The contribution of active iron-uptake to Acinetobacter baumannii pathogenicity.

Runci F, Gentile V, Frangipani E, Rampioni G, Leoni L, Lucidi M, Visaggio D, Harris G, Chen W, Stahl J, Averhoff B, Visca P.

Infect Immun. 2019 Feb 4. pii: IAI.00755-18. doi: 10.1128/IAI.00755-18. [Epub ahead of print]

PMID:
30718286
2.

The antimetabolite 3-bromopyruvate selectively inhibits Staphylococcus aureus.

Visca P, Pisa F, Imperi F.

Int J Antimicrob Agents. 2018 Nov 22. pii: S0924-8579(18)30333-9. doi: 10.1016/j.ijantimicag.2018.11.008. [Epub ahead of print]

PMID:
30472291
3.

Alkyl-guanidine Compounds as Potent Broad-Spectrum Antibacterial Agents: Chemical Library Extension and Biological Characterization.

Pasero C, D'Agostino I, De Luca F, Zamperini C, Deodato D, Truglio GI, Sannio F, Del Prete R, Ferraro T, Visaggio D, Mancini A, Guglielmi MB, Visca P, Docquier JD, Botta M.

J Med Chem. 2018 Oct 25;61(20):9162-9176. doi: 10.1021/acs.jmedchem.8b00619. Epub 2018 Oct 11.

PMID:
30265809
4.

Antimicrobial Activity of Gallium Compounds on ESKAPE Pathogens.

Hijazi S, Visaggio D, Pirolo M, Frangipani E, Bernstein L, Visca P.

Front Cell Infect Microbiol. 2018 Sep 10;8:316. doi: 10.3389/fcimb.2018.00316. eCollection 2018.

5.

Identification of FDA-Approved Drugs as Antivirulence Agents Targeting the pqs Quorum-Sensing System of Pseudomonas aeruginosa.

D'Angelo F, Baldelli V, Halliday N, Pantalone P, Polticelli F, Fiscarelli E, Williams P, Visca P, Leoni L, Rampioni G.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e01296-18. doi: 10.1128/AAC.01296-18. Print 2018 Nov.

PMID:
30201815
6.

PD-L1 Testing in Lung Cancer: An International Pathologist's Initiative in an Unknown "Middle Earth".

Marino M, Visca P, Ottaviano M.

J Thorac Oncol. 2018 Sep;13(9):1239-1241. doi: 10.1016/j.jtho.2018.06.014. No abstract available.

PMID:
30166010
7.

hMENA isoforms impact NSCLC patient outcome through fibronectin/β1 integrin axis.

Di Modugno F, Spada S, Palermo B, Visca P, Iapicca P, Di Carlo A, Antoniani B, Sperduti I, Di Benedetto A, Terrenato I, Mottolese M, Gandolfi F, Facciolo F, Chen EI, Schwartz MA, Santoni A, Bissell MJ, Nisticò P.

Oncogene. 2018 Oct;37(42):5605-5617. doi: 10.1038/s41388-018-0364-3. Epub 2018 Jun 15.

8.

An essential transcriptional regulator: the case of Pseudomonas aeruginosa Fur.

Visca P, Imperi F.

Future Microbiol. 2018 Jun 1;13:853-856. doi: 10.2217/fmb-2018-0081. Epub 2018 Jun 7. No abstract available.

PMID:
29877110
9.

New Shuttle Vectors for Gene Cloning and Expression in Multidrug-Resistant Acinetobacter Species.

Lucidi M, Runci F, Rampioni G, Frangipani E, Leoni L, Visca P.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e02480-17. doi: 10.1128/AAC.02480-17. Print 2018 Apr.

10.

Studies of Pseudomonas aeruginosa Mutants Indicate Pyoverdine as the Central Factor in Inhibition of Aspergillus fumigatus Biofilm.

Sass G, Nazik H, Penner J, Shah H, Ansari SR, Clemons KV, Groleau MC, Dietl AM, Visca P, Haas H, Déziel E, Stevens DA.

J Bacteriol. 2017 Dec 5;200(1). pii: e00345-17. doi: 10.1128/JB.00345-17. Print 2018 Jan 1.

11.

Effect of efflux pump inhibition on Pseudomonas aeruginosa transcriptome and virulence.

Rampioni G, Pillai CR, Longo F, Bondì R, Baldelli V, Messina M, Imperi F, Visca P, Leoni L.

Sci Rep. 2017 Sep 12;7(1):11392. doi: 10.1038/s41598-017-11892-9.

12.

Ferric Uptake Regulator Fur Is Conditionally Essential in Pseudomonas aeruginosa.

Pasqua M, Visaggio D, Lo Sciuto A, Genah S, Banin E, Visca P, Imperi F.

J Bacteriol. 2017 Oct 17;199(22). pii: e00472-17. doi: 10.1128/JB.00472-17. Print 2017 Nov 15.

13.

IL-18 receptor marks functional CD8+ T cells in non-small cell lung cancer.

Timperi E, Focaccetti C, Gallerano D, Panetta M, Spada S, Gallo E, Visca P, Venuta F, Diso D, Prelaj A, Longo F, Facciolo F, Nisticò P, Barnaba V.

Oncoimmunology. 2017 May 12;6(7):e1328337. doi: 10.1080/2162402X.2017.1328337. eCollection 2017.

14.

Synthesis and Structural Characterization of Silver Nanoparticles Stabilized with 3-Mercapto-1-Propansulfonate and 1-Thioglucose Mixed Thiols for Antibacterial Applications.

Porcaro F, Carlini L, Ugolini A, Visaggio D, Visca P, Fratoddi I, Venditti I, Meneghini C, Simonelli L, Marini C, Olszewski W, Ramanan N, Luisetto I, Battocchio C.

Materials (Basel). 2016 Dec 20;9(12). pii: E1028. doi: 10.3390/ma9121028.

15.

tsRNA signatures in cancer.

Balatti V, Nigita G, Veneziano D, Drusco A, Stein GS, Messier TL, Farina NH, Lian JB, Tomasello L, Liu CG, Palamarchuk A, Hart JR, Bell C, Carosi M, Pescarmona E, Perracchio L, Diodoro M, Russo A, Antenucci A, Visca P, Ciardi A, Harris CC, Vogt PK, Pekarsky Y, Croce CM.

Proc Natl Acad Sci U S A. 2017 Jul 25;114(30):8071-8076. doi: 10.1073/pnas.1706908114. Epub 2017 Jul 10.

16.

Understanding the biomimetic properties of gallium in Pseudomonas aeruginosa: an XAS and XPS study.

Porcaro F, Bonchi C, Ugolini A, Frangipani E, Polzonetti G, Visca P, Meneghini C, Battocchio C.

Dalton Trans. 2017 May 30;46(21):7082-7091. doi: 10.1039/c7dt00651a.

PMID:
28524209
17.

The multi-output incoherent feedforward loop constituted by the transcriptional regulators LasR and RsaL confers robustness to a subset of quorum sensing genes in Pseudomonas aeruginosa.

Bondí R, Longo F, Messina M, D'Angelo F, Visca P, Leoni L, Rampioni G.

Mol Biosyst. 2017 Jun 1;13(6):1080-1089. doi: 10.1039/c7mb00040e. Epub 2017 May 3.

PMID:
28466892
18.

Identification by High-Throughput Screening of Pseudomonas Acyl-Coenzyme A Synthetase Inhibitors.

Turcano L, Visaggio D, Frangipani E, Missineo A, Andreini M, Altamura S, Visca P, Bresciani A.

SLAS Discov. 2017 Aug;22(7):897-905. doi: 10.1177/2472555216689283. Epub 2017 Jan 31.

PMID:
28346095
19.

Gallium-Protoporphyrin IX Inhibits Pseudomonas aeruginosa Growth by Targeting Cytochromes.

Hijazi S, Visca P, Frangipani E.

Front Cell Infect Microbiol. 2017 Jan 26;7:12. doi: 10.3389/fcimb.2017.00012. eCollection 2017.

20.

Unravelling the Genome-Wide Contributions of Specific 2-Alkyl-4-Quinolones and PqsE to Quorum Sensing in Pseudomonas aeruginosa.

Rampioni G, Falcone M, Heeb S, Frangipani E, Fletcher MP, Dubern JF, Visca P, Leoni L, Cámara M, Williams P.

PLoS Pathog. 2016 Nov 16;12(11):e1006029. doi: 10.1371/journal.ppat.1006029. eCollection 2016 Nov.

21.

Acinetobacter baumannii Biofilm Formation in Human Serum and Disruption by Gallium.

Runci F, Bonchi C, Frangipani E, Visaggio D, Visca P.

Antimicrob Agents Chemother. 2016 Dec 27;61(1). pii: e01563-16. doi: 10.1128/AAC.01563-16. Print 2017 Jan.

22.

Mesothelioma families without inheritance of a BAP1 predisposing mutation.

Ascoli V, Cozzi I, Vatrano S, Izzo S, Giorcelli J, Romeo E, Carnovale-Scalzo C, Grillo LR, Facciolo F, Visca P, Papotti M, Righi L.

Cancer Genet. 2016 Sep;209(9):381-387. doi: 10.1016/j.cancergen.2016.07.002. Epub 2016 Jul 18.

23.

Legionellosis in the occupational setting.

Principe L, Tomao P, Visca P.

Environ Res. 2017 Jan;152:485-495. doi: 10.1016/j.envres.2016.09.018. Epub 2016 Oct 4. Review.

PMID:
27717486
24.

Usefulness of conventional transbronchial needle aspiration in the diagnosis, staging and molecular characterization of pulmonary neoplasias by thin-prep based cytology: experience of a single oncological institute.

Ramieri MT, Marandino F, Visca P, Salvitti T, Gallo E, Casini B, Giordano FR, Frigieri C, Caterino M, Carlini S, Rinaldi M, Ceribelli A, Pennetti A, Alò PL, Marino M, Pescarmona E, Filippetti M.

J Thorac Dis. 2016 Aug;8(8):2128-37. doi: 10.21037/jtd.2016.07.62.

25.

Membrane localization and topology of the DnpA protein control fluoroquinolone tolerance in Pseudomonas aeruginosa.

Liebens V, Frangipani E, Van der Leyden A, Fauvart M, Visca P, Michiels J.

FEMS Microbiol Lett. 2016 Sep;363(17). pii: fnw184. doi: 10.1093/femsle/fnw184. Epub 2016 Jul 31.

PMID:
27481702
26.

Development of inhalable hyaluronan/mannitol composite dry powders for flucytosine repositioning in local therapy of lung infections.

Costabile G, d'Angelo I, d'Emmanuele di Villa Bianca R, Mitidieri E, Pompili B, Del Porto P, Leoni L, Visca P, Miro A, Quaglia F, Imperi F, Sorrentino R, Ungaro F.

J Control Release. 2016 Sep 28;238:80-91. doi: 10.1016/j.jconrel.2016.07.029. Epub 2016 Jul 19.

PMID:
27449745
27.

Role of Iron Uptake Systems in Pseudomonas aeruginosa Virulence and Airway Infection.

Minandri F, Imperi F, Frangipani E, Bonchi C, Visaggio D, Facchini M, Pasquali P, Bragonzi A, Visca P.

Infect Immun. 2016 Jul 21;84(8):2324-2335. doi: 10.1128/IAI.00098-16. Print 2016 Aug.

28.

Oral Metformin Ameliorates Bleomycin-Induced Skin Fibrosis.

Ursini F, Grembiale RD, D'Antona L, Gallo E, D'Angelo S, Citraro R, Visca P, Olivieri I, De Sarro G, Perrotti N, Russo E.

J Invest Dermatol. 2016 Sep;136(9):1892-1894. doi: 10.1016/j.jid.2016.05.097. Epub 2016 May 29. No abstract available.

29.

Interaction between the human papillomavirus 16 E7 oncoprotein and gelsolin ignites cancer cell motility and invasiveness.

Matarrese P, Abbruzzese C, Mileo AM, Vona R, Ascione B, Visca P, Rollo F, Benevolo M, Malorni W, Paggi MG.

Oncotarget. 2016 Aug 9;7(32):50972-50985. doi: 10.18632/oncotarget.8646.

30.

Biological Characterization and in Vivo Assessment of the Activity of a New Synthetic Macrocyclic Antifungal Compound.

Deodato D, Maccari G, De Luca F, Sanfilippo S, Casian A, Martini R, D'Arezzo S, Bonchi C, Bugli F, Posteraro B, Vandeputte P, Sanglard D, Docquier JD, Sanguinetti M, Visca P, Botta M.

J Med Chem. 2016 Apr 28;59(8):3854-66. doi: 10.1021/acs.jmedchem.6b00018. Epub 2016 Apr 19.

PMID:
27045868
31.

Structural Biology of Bacterial Haemophores.

Ascenzi P, di Masi A, Leboffe L, Frangipani E, Nardini M, Verde C, Visca P.

Adv Microb Physiol. 2015;67:127-76. doi: 10.1016/bs.ampbs.2015.09.002. Epub 2015 Oct 27.

PMID:
26616517
32.

Preclinical model in HCC: the SGK1 kinase inhibitor SI113 blocks tumor progression in vitro and in vivo and synergizes with radiotherapy.

Talarico C, D'Antona L, Scumaci D, Barone A, Gigliotti F, Fiumara CV, Dattilo V, Gallo E, Visca P, Ortuso F, Abbruzzese C, Botta L, Schenone S, Cuda G, Alcaro S, Bianco C, Lavia P, Paggi MG, Perrotti N, Amato R.

Oncotarget. 2015 Nov 10;6(35):37511-25. doi: 10.18632/oncotarget.5527.

33.

The role of vancomycin in addition with colistin and meropenem against colistin-sensitive multidrug resistant Acinetobacter baumannii causing severe infections in a Paediatric Intensive Care Unit.

Ceccarelli G, Oliva A, d'Ettorre G, D'Abramo A, Caresta E, Barbara CS, Mascellino MT, Papoff P, Moretti C, Vullo V, Visca P, Venditti M.

BMC Infect Dis. 2015 Sep 30;15:393. doi: 10.1186/s12879-015-1133-3.

34.

Cell aggregation promotes pyoverdine-dependent iron uptake and virulence in Pseudomonas aeruginosa.

Visaggio D, Pasqua M, Bonchi C, Kaever V, Visca P, Imperi F.

Front Microbiol. 2015 Aug 28;6:902. doi: 10.3389/fmicb.2015.00902. eCollection 2015.

35.

An asbestos-exposed family with multiple cases of pleural malignant mesothelioma without inheritance of a predisposing BAP1 mutation.

Cheung M, Kadariya Y, Pei J, Talarchek J, Facciolo F, Visca P, Righi L, Cozzi I, Testa JR, Ascoli V.

Cancer Genet. 2015 Oct;208(10):502-7. doi: 10.1016/j.cancergen.2015.07.004. Epub 2015 Jul 30.

36.

Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer.

Sette G, Salvati V, Mottolese M, Visca P, Gallo E, Fecchi K, Pilozzi E, Duranti E, Policicchio E, Tartaglia M, Milella M, De Maria R, Eramo A.

Cell Death Dis. 2015 Aug 6;6:e1850. doi: 10.1038/cddis.2015.217.

37.

Pyoverdine and proteases affect the response of Pseudomonas aeruginosa to gallium in human serum.

Bonchi C, Frangipani E, Imperi F, Visca P.

Antimicrob Agents Chemother. 2015 Sep;59(9):5641-6. doi: 10.1128/AAC.01097-15. Epub 2015 Jul 6.

38.

Functional and Spectroscopic Characterization of Chlamydomonas reinhardtii Truncated Hemoglobins.

Ciaccio C, Ocaña-Calahorro F, Droghetti E, Tundo GR, Sanz-Luque E, Polticelli F, Visca P, Smulevich G, Ascenzi P, Coletta M.

PLoS One. 2015 May 20;10(5):e0125005. doi: 10.1371/journal.pone.0125005. eCollection 2015.

39.

Prognostic role of serum p53 antibodies in lung cancer.

Mattioni M, Soddu S, Prodosmo A, Visca P, Conti S, Alessandrini G, Facciolo F, Strigari L.

BMC Cancer. 2015 Mar 18;15:148. doi: 10.1186/s12885-015-1174-4.

40.

An 18-year delay in the clinical presentation of bronchial carcinoid.

Leuzzi G, Forcella D, Melis E, Visca P, Facciolo F.

Rev Esp Med Nucl Imagen Mol. 2015 Sep-Oct;34(5):327-8. doi: 10.1016/j.remn.2014.12.008. Epub 2015 Jan 24. No abstract available.

41.

Sema6A and Mical1 control cell growth and survival of BRAFV600E human melanoma cells.

Loria R, Bon G, Perotti V, Gallo E, Bersani I, Baldassari P, Porru M, Leonetti C, Di Carlo S, Visca P, Brizzi MF, Anichini A, Mortarini R, Falcioni R.

Oncotarget. 2015 Feb 20;6(5):2779-93.

42.

Iron and Acinetobacter baumannii Biofilm Formation.

Gentile V, Frangipani E, Bonchi C, Minandri F, Runci F, Visca P.

Pathogens. 2014 Aug 18;3(3):704-19. doi: 10.3390/pathogens3030704.

43.

Biopsy of different oral soft tissues lesions by KTP and diode laser: histological evaluation.

Romeo U, Russo C, Palaia G, Lo Giudice R, Del Vecchio A, Visca P, Migliau G, De Biase A.

ScientificWorldJournal. 2014;2014:761704. doi: 10.1155/2014/761704. Epub 2014 Oct 27.

44.

Prognostic impact of alternative splicing-derived hMENA isoforms in resected, node-negative, non-small-cell lung cancer.

Bria E, Di Modugno F, Sperduti I, Iapicca P, Visca P, Alessandrini G, Antoniani B, Pilotto S, Ludovini V, Vannucci J, Bellezza G, Sidoni A, Tortora G, Radisky DC, Crinò L, Cognetti F, Facciolo F, Mottolese M, Milella M, Nisticò P.

Oncotarget. 2014 Nov 30;5(22):11054-63.

45.

Ovarian metastasis from thyroid carcinoma: a case report and literature review.

Corrado G, Pomati G, Russo A, Visca P, Vincenzoni C, Patrizi L, Vizza E.

Diagn Pathol. 2014 Oct 30;9:193. doi: 10.1186/s13000-014-0193-9. Review.

46.

Characterization of Streptococcus pneumoniae clones from paediatric patients with cystic fibrosis.

Pimentel de Araujo F, D'Ambrosio F, Camilli R, Fiscarelli E, Di Bonaventura G, Baldassarri L, Visca P, Pantosti A, Gherardi G.

J Med Microbiol. 2014 Dec;63(Pt 12):1704-15. doi: 10.1099/jmm.0.072199-0. Epub 2014 Oct 9.

PMID:
25301526
47.

Nitrosylation mechanisms of Mycobacterium tuberculosis and Campylobacter jejuni truncated hemoglobins N, O, and P.

Ascenzi P, di Masi A, Tundo GR, Pesce A, Visca P, Coletta M.

PLoS One. 2014 Jul 22;9(7):e102811. doi: 10.1371/journal.pone.0102811. eCollection 2014.

48.

Pyochelin potentiates the inhibitory activity of gallium on Pseudomonas aeruginosa.

Frangipani E, Bonchi C, Minandri F, Imperi F, Visca P.

Antimicrob Agents Chemother. 2014 Sep;58(9):5572-5. doi: 10.1128/AAC.03154-14. Epub 2014 Jun 23.

49.

Lymphatic and blood vasculature in primary cutaneous melanomas of the scalp and neck.

Pasquali S, Montesco MC, Ginanneschi C, Baroni G, Miracco C, Urso C, Mele F, Lombardi AR, Quaglino P, Cattaneo L, Staibano S, Botti G, Visca P, Zannoni M, Soda G, Corti B, Pilloni L, Anselmi L, Lissia A, Vannucchi M, Manieli C, Massi D.

Head Neck. 2015 Nov;37(11):1596-602. doi: 10.1002/hed.23801. Epub 2014 Aug 4.

PMID:
24931916
50.

Cell-surface signaling in Pseudomonas: stress responses, iron transport, and pathogenicity.

Llamas MA, Imperi F, Visca P, Lamont IL.

FEMS Microbiol Rev. 2014 Jul;38(4):569-97. doi: 10.1111/1574-6976.12078. Epub 2014 Jul 2. Review.

Supplemental Content

Support Center